In this section
Early stage research
Children's Wisconsin is among the top centers in the world for the treatment of pediatric cancer, with the capability and resources available to conduct early-phase (Phase I & II) clinical trials. As a member of several early-phase research consortia, Children's offers patients and families access to new, innovative treatment options. In addition, we offer several early phase studies developed by our own researchers as well as multi-center clinical trials initiated by our partners at leading programs around the country.
Spotlight on clinical trials
Some of our recent investigator-initiated clinical trials include:
- Phase 1 study of bispecific CAR-T cells for patients with relapsed or refractory CD19 or CD20 B-cell Acute Lymphoblastic Leukemia
- Phase 2 study, Blinatumomab Bridging Therapy in High-Risk B-Acute Lymphoblastic Leukemia
- Pilot Study of T-cell and B-cell Depleted Allogeneic Transplant followed by Blinatumomab therapy for High-Risk B-Acute Lymphoblastic Leukemia
- Parent-to-Child (Haplo) Transplant for patients with sickle cell disease
For more information about cancer and blood disorders clinical trials, email us or call
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
"The steady improvement in survival for children with cancer is a direct result of their enrollment onto clinical trials; without which we would remain decades behind in terms of scientific advances in pediatric cancer." ~Michael J. Burke, MD